中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码
姓名: 王晖
职称: 主任医师 教授
单位: 瑞金医院 感染科
简历介绍:

1992.7-现在   瑞金医院感染科

2002.8-2003.4  日本国立病院长崎医疗中心  助理研究员

2003.8-2005.4  美国德州医学中心贝勒医学院  博士后

成果:

上海市公共卫生优秀学科带头人、上海市科技一等奖、上海市医学科技一等奖、华夏医学科技一等奖、中华医学科技三等奖 
论文:
1.Ding Y, Liu K, Xu Y, Zhao Q, Lou S, Xiang X, Yan L, Cao Z, Xie Q, Zhu C, Bao S, Wang H. Combination of inflammatory scorever function and AFP improves the diagnostic accuracy of HBV-related hepatocellular carcinoma.Cancer Med. 2020 May;9(9):3057-3069. (通讯作者)
2.Feng M, Liu K, Zhao G, Lou S, An B, Lin L, Ding Y, Bao S,Wang H. A novel model based on qAnti-HBc and conventional biomarkers for identifying significant liver injury among CHB patients with ALT ≤ ULN. Antiviral Res. 2022 Apr 6;202:105315. (通讯作者)
3.Liu K, Ding Y, Wang Y, Zhao Q, Yan L, Xie J, Liu Y, Xie Q, Cai W, Bao S, Wang H. Combination of IL-34 and AFP improves the diagnostic value during the development of HBV related hepatocellular carcinoma. Clin Exp Med. 2022 Mar 28. (通讯作者)
4.Zhao Q, Liu K, Zhu X, Yan L, Ding Y, Xu Y, Lou S, Zhao G, Xie Q, Gao Y, Bao S,Wang H. Anti-viral effect in chronic hepatitis B patients with normal or mildly elevated alanine aminotransferase.Antiviral Res. 2020 Dec;184:104953. (通讯作者)
5.Liwen Chen, Zhujun Cao, Lei Yan, Yezhou Ding, Xinghua Shen, Kehui Liu,Xiaogang Xiang, Qing Xie, Chuanwu Zhu, Shisan Bao and Hui Wang. Circulating receptor-Interacting protein kinase are increased in HBV patients with acute-on-chronic liver failure and are associated withclinical outcome. Frontiers in Physiology, 2020 Jun 16;11:526. (通讯作者)
6.Cao Z, Chen L, Li J, Liu Y, Bao R, Liu K, Yan L, Ding Y, Guo Q, Xiang X, Xie J, Lin L,Xie Q, Bao S, Wang H. Serum keratin-18 fragments as cell death biomarker in association with disease progression and prognosis in hepatitis B virus-related cirrhosis. J Viral Hepat.2019 Jul;26(7):835-845.(通讯作者) 
7.Liu K, Chen L, Zhao G, Cao Z, Li F, Lin L, Zhu C, Xie Q, Xu Y, Bao S, Wang H. IPS-1 polymorphisms in regulating interferon response in HBV infection. Biosci Trends. 2019;13(2):130-135. (通讯作者) 
8.Yan L, Zhu C, Li J, Chen L, Ding Y, Cao Z, Liu K, Lin L, Tang W, Xie Q, Xu Y, Bao S, Wang H. Entecavir add-on or switch-to pegylated interferon improves HBsAg  clearance in HBe antigen negative chronic hepatitis B patients. Infect Drug Resist. 2018;11:2001-2009. (通讯作者) 
9.Chen L, Zhu C, Li F, Wang Y, Bao R, Cao Z, Xiang X, Yan L, Lin L, Zhao G, Xie Q, Bao S, Wang H. Correlation between hepatic human males absent on the first (hMOF) and viral persistence in chronic hepatitis B patients. Cell Biosci. 2018;8:14. (通讯作者) 
10.Cao Z, Li Z, Wang H, Liu Y, Xu Y, Mo R, Ren P, Chen L, Lu J, Li H, Zhuang Y, Liu Y,    Wang X, Zhao G, Tang W, Xiang X, Cai W, Liu L, Bao S, Xie Q. Algorithm of Golgi     protein 73 and liver stiffness accurately diagnoses significant fibrosis in chronic HBV infection. Liver Int. 2017;37(11):1612-1621. (共同第一作者) 
11.Wang Y, Xiang X, Chen L, Cao Z, Bao R, Zhou H, Tang W, Lu J, Lin L, Xie Q, Bao S, Wang H. Randomized clinical trial: Nucleos(t)ide analogues improved survival of CHB-related HCC patients via reducing severity and progression of malignancy. Oncotarget. 2016;7(36):58553-58562. (通讯作者) 
12.Liu K, Xiang X, Bao R, Chen R, Liu Y, Xie J, Guo Q, Bao S, Xie Q, Wang H. A five years study of antiviral effect of entecavir in Chinese chronic hepatitis B patients. Sci Rep. 2016;6:28779. (通讯作者) 
13.Cao ZJ, Li J, Wang Y, Bao R, Liu YH, Xiang XG, Lin LY, Ye FX, Lu J, Xie Q, Bao SS, Wang H. Serum hepatocyte apoptosis biomarker predicts the presence of significant histological lesion in chronic hepatitis B virus infection. Dig Liver Dis. 2016;48(12):1463-1470. (通讯作者)
14.Wu H, Zhao G, Qian F, Liu K, Xie J, Zhou H, Xu J, Xu Y, Han Y, Xie Q, Wang H. Association of IL28B polymorphisms with peginterferon treatment response in Chinese Han patients with HBeAg-positive chronic hepatitis B. Liver Int. 2015;35(2):473-481. (通讯作者)
Cao Z, Li F, Xiang X, Liu K, Liu Y, Tang W, Lin L, Guo Q, Bao S, Xie Q, Wang H. Circulating cell death biomarker: good candidates of prognostic indicator for patients with hepatitis B virus related acute-on-chronic liver failure. Sci Rep. 2015;5:14240. (通讯作者)
  

对于给您带来的不便,我们深表歉意:我们正在采取措施防止机器人程序和页面爬虫程序提交欺诈性表单。请输入正确的验证码来证明你是人类。